MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
IDEXX Laboratories ROE Ratio 2011-2026 | IDXX
Annual ROE Ratio IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65.99 | 55.65 | 56.92 | 111.56 | 107.95 | 91.94 | 240.53 | -4083.52 | -488.73 | -205.19 | -228.68 | 154.7 | 36.24 | 28.02 | 29.98 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 240.53 | -4083.52 | -268.44 |
Quarterly ROE Ratio IDEXX Laboratories
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68.89 | 65.69 | 58.4 | 42.27 | 58.63 | 60.6 | 68.23 | 62.31 | 100.32 | 121.97 | 130.35 | 97.21 | 120.4 | 105.59 | 103.79 | 79.32 | 102.45 | 102.39 | 98.87 | 64.39 | 115.38 | 153.57 | 200.84 | 241.01 | -710.21 | -1751.78 | -2965.16 | -3963.32 | -3133.81 | -2283.88 | -1299.09 | -486.35 | -463.97 | -385.76 | -290.02 | -204.93 | -209.31 | -209.78 | -215.41 | -228.32 | -153.52 | -56.58 | 59.76 | 154.79 | 141.05 | 105.5 | 67.23 | 36.24 | 34.71 | 32.63 | 30.27 | 28.02 | 28.25 | 28.65 | 29.6 | 29.98 | 7.14 | 9.02 | 6.79 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 241.01 | -3963.32 | -267.1 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 119.52 | -0.71 % | $ 36.3 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 20.48 | 2.97 % | $ 220 M |  China |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.68 | 0.28 % | $ 942 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.41 | 2.18 % | $ 1.88 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.57 | 0.82 % | $ 682 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 181.55 | 1.25 % | $ 9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 517.53 | -0.47 % | $ 14.9 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 197.46 | -0.54 % | $ 141 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 132.48 | 1.66 % | $ 21.1 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 208.26 | -2.97 % | $ 20.5 B | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.63 | 3.35 % | $ 1.11 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.19 | 1.06 % | $ 490 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 29.05 | -0.12 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
-2.49 | $ 28.71 | 0.74 % | $ 46.1 M | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Guardant Health
GH
|
419.18 | $ 84.85 | -1.79 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.21 | 6.01 % | $ 482 M | USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.89 | 0.35 % | $ 93.8 K | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.87 | 1.78 % | $ 287 M | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.09 | -0.64 % | $ 4.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 116.45 | 3.0 % | $ 9.61 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 267.54 | -0.49 % | $ 22.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.61 | -0.02 % | $ 2.67 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 122.68 | 1.51 % | $ 5.74 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.48 | -1.35 % | $ 2.06 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 83.57 | 1.0 % | $ 5.64 B | USA |
 |
Neuronetics
STIM
|
-174.27 | $ 1.39 | -3.15 % | $ 91.7 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 191.67 | -1.23 % | $ 21.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 5.07 | 2.22 % | $ 3.99 M | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 530.89 | 0.68 % | $ 200 B | USA |